NEU neuren pharmaceuticals limited

ROW Rights, page-8

  1. 838 Posts.
    lightbulb Created with Sketch. 314

    ACADIA has taken on very minimal risk with their back ended deal, why would they significantly risk and spend millions on buying out NEU with the potential of basically having it worthless if Ph.3 fails?

    Or

    They could propose another backended deal that also significantly reduces their exposure to a failing market by paying for positive milstones achieved. ACADIA is negotiating from a position of strength seen as they already have NA rights, management need to be willing to walk away in order to get a FRONT loaded deal.

    NEU is leaky, somehow people are finding out things or 'somehow' anticiapte the correct results by either dumping or buying......IMO the SP is talking again and once again no one is listening.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.76
Change
0.170(1.17%)
Mkt cap ! $1.837B
Open High Low Value Volume
$14.36 $14.86 $14.25 $3.707M 254.0K

Buyers (Bids)

No. Vol. Price($)
1 2500 $14.70
 

Sellers (Offers)

Price($) Vol. No.
$14.80 1000 1
View Market Depth
Last trade - 16.10pm 16/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.